About Acrongenomics

About company

Acrongenomics, Inc. is a U.S. publicly traded company (OTC Markets/AGNM) that focuses on developing and commercializing novel biotechnology platforms in the Life Science sector as well as introducing and developing promising new compounds in the Pharmaceutical sector. Our goal is to bring novel and realistic concepts to market by transforming scientific innovations into tangible, customer orientated applications.